Ottawa abusing access to information law to avoid releasing documents, watchdog says
The Information Commissioner is calling on the government to stop relying on legal exemptions she says are overused
Ottawa abusing access to information law to avoid releasing documents, watchdog says. The Information Commissioner is calling on the government to stop relying on legal exemptions she says are overused.
www.theglobeandmail.com/politics/art... via @theglobeandmail.com #FOI #SecretCanada
28.09.2025 23:50 β π 21 π 6 π¬ 0 π 0
Rights Groups Call for Probe of World Bank Hospital Funding
More than 50 human rights organizations, nonprofits and international development experts are calling on the World Bank to investigate its health-care investments in Africa and Asia, citing Bloomberg ...
π¨@WorldBank's mission is to fight poverty, yet @IFC_org is funding high-end unaffordable hospitals & exacerbating inequality? This approach will not deliver on the WBs target to reach 1.5 billion with access to quality healthcare! #UHC #PeopleOverProfits www.bloomberg.com/news/article...
23.09.2025 08:06 β π 4 π 1 π¬ 0 π 0
Live in the Halifax area but concerned about global health?
This talk on Thursday featuring @stephanienolen.bsky.social is NOT to be missed!
22.09.2025 16:04 β π 0 π 0 π¬ 0 π 0
New paper alert! Led by @hollylynchez.bsky.social we report findings from interviews with reps from @fda.gov, pharma, patient orgs + payers about the challenges involved in securing rigorous safety/efficacy evidence re: drugs granted accelerated approval.
See the thread below for details.
22.09.2025 10:56 β π 1 π 0 π¬ 0 π 0
RFK Jr., American Psycho
He needs to go. Now.
Good morning America. Happy Monday. And #RFKJr still needs to go. Now. My piece in @thenation.com last week. www.thenation.com/article/soci...
08.09.2025 09:50 β π 564 π 156 π¬ 20 π 5
Iβll answer if you say who you are.
05.09.2025 23:11 β π 0 π 0 π¬ 0 π 0
This is a fake account and pure misogyny. Iβm at a complete loss.
05.09.2025 22:45 β π 0 π 0 π¬ 0 π 0
Paul Magennis and Kim Carlson continue to do great work responding to irresponsible journalism spreading myths, mis-, and disinformation about MAiD in Canada.
19.08.2025 19:34 β π 2 π 1 π¬ 1 π 0
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
@stephanienolen.bsky.social's piece on the destruction of the South African biomedical research effort by the Trump Administration is a must-read. Please circulate. This is a disaster for South Africa AND the world. www.nytimes.com/2025/06/17/h...
17.06.2025 10:27 β π 126 π 95 π¬ 4 π 4
Just shy of 3 years ago the BC gov settled its case against #PurduePharma. In addition to the $ secured, "additional benefits" in the form of "access to information + documents" were promised to be made public.
Has any of that info ever emerged? Asking for a friend
news.gov.bc.ca/releases/202...
12.06.2025 15:21 β π 0 π 0 π¬ 0 π 0
Safe supply an effective treatment tool despite political backlash, study confirms - Healthy Debate
New study shows that safe supply may be a more effective treatment option than methadone for those most at risk,.
#SaferSupply an effective treatment tool despite political backlash. New study shows safe opioid supply more effective than opioid agonist therapies, by @maddidellplain.bsky.social healthydebate.ca/2025/06/topi... via @healthydebate.bsky.social
12.06.2025 14:56 β π 23 π 11 π¬ 0 π 0
Wow, and among the questionable folks that replaced them is Robert Malone, a scientist who still appears to be bitter for -- in his words in the article in @nature.com below -- being "written out of the history" of mRNA.
Talk about an agenda.
www.nature.com/articles/d41...
12.06.2025 12:39 β π 0 π 0 π¬ 0 π 0
πTransparency in the pharmaceutical sector is not only a matter of democratic accountability β itβs a global health imperative.
π
Join us on June 12th for an online event exploring how civil society is advancing pharmaceutical transparency with cases from South Africa, Colombia, and Spain
10.06.2025 12:52 β π 4 π 2 π¬ 1 π 0
Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond | Journal of Law, Medicine & Ethics | Cambridge Core
Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond
Must Read:
Law & Global Governance of Infectious Disease: Access to Medicines on COVID, AIDS, & Beyond
Via:
American Society of Law, Medicine & Ethics Journal
Cambridge Univ. Press
@ASLMENews
Matthew Kavanagh
Luis G Abinader
Fatima Hassan
Eric Friedman
Link:
www.cambridge.org/core/journal...
15.05.2025 07:18 β π 3 π 3 π¬ 1 π 0
To be clear, I don't know whether NIH has a claim to Ridgeback's PRV if/when it's sold. The license terms are not, to my knowledge, publicly available b/c Ridgeback is a private company.
Maybe it's time to FOIA NIH to see how many PRVs it has a financial stake in.
/end.
14.05.2025 17:36 β π 0 π 0 π¬ 0 π 0
That might explain why many of the deals, like the one NIH struck with Ridgeback, end up being exclusive. NIH wants a cut of the PRV if the product is approved. In return, the company gets exclusivity. /7
14.05.2025 17:36 β π 0 π 0 π¬ 1 π 0
I learned recently that the US National Institutes of Health often takes a financial stake in any PRVs that the IP they license out. /6
14.05.2025 17:36 β π 0 π 0 π¬ 1 π 0
We should expect nothing less when we use the market to solve public health problems.
But what if the state, as the holder of the IP, approaches its licensing negotiations with the financial rewards foremost in mind? /5
14.05.2025 17:36 β π 0 π 0 π¬ 1 π 0
Quick follow up thread:
It is always baffling *at first* to learn that an important health intervention like an Ebola therapeutic - substantially developed by the public sector - has been licensed exclusively to a private company..../1
14.05.2025 17:36 β π 1 π 1 π¬ 1 π 0
Yuanquiong Hu from @msf.ca access walking us through the long road to Ebola therapeutics, detailing how publicly funded science came to be privately controlled.
14.05.2025 17:05 β π 1 π 0 π¬ 1 π 1
Andy Hill breaking down, with gut wrenching clarity, the difference between the price (charged by big pharma) & (far lower) cost of making medicines @itpc.bsky.social
14.05.2025 10:40 β π 2 π 1 π¬ 0 π 0
Health journalist, contributing opinion writer @nytimes Formerly @voxdotcom, @MIT Knight Fellow etc. Book: https://tinyurl.com/yx2kmsp4
Academic lawyer/bioethicist studying pharmaceutical policy, access to investigational medicines, IRB quality (www.aereo.org), and clinical research ethics and regulation, with a splash of psychedelics.
representing 1000+ professors, instructors, librarians and counsellors at Dalhousie University
A trusted voice at the intersection of research, society and public policy, convening expertise and assessing knowledge to advance evidence-informed decision-making in Canada and internationally
π¬ https://bit.ly/cca-advance
π» https://www.cca-reports.ca
Global health ; pharmaceutical policy ; health equity ; migration policy
Research and advocacy manager at https://saludporderecho.org/quienes-somos/
This account isn't currently active | Ce compte est actuellement inactif. Veuillez plutΓ΄t suivre : @msf.ca.
hootbio.com/DoctorsWithoutBorders
I'm running a group called Voices in Action - People Living with Diabetes in Global Health. I have type 1 diabetes and want people to stop dying from this condition. Access to insulin is a human right #insulin4all #diabetes #t1d
Community-led Monitoring (CLM). Social Justice. Advocacy. Science is real. Womenβs rights are human rights. Citizen Science Lead @ ITPC. Views are my own.
Reporter for The Canadian Press in Ottawa. Writing about defence, trade and more. I turn coffee into words.
Founded by Dr. Sheryl Spithoff based @wchospital.bsky.social
Conducting research at the intersection of digital information technologies, commercial interests and health systems
https://www.healthtechandsocietylab.org/
ITPC is an issue-based global organization working to achieve health and social justice for all through robust community engagement.
Law prof at @uottawa.ca @ottawahealthlaw.ca in international & public law, global/public health, & human rights β’ Iranian-Canadian β’ love rescue dogs, cortados and waterfront runs β’ my works at www.roojinhabibi.org
Strategist β’ Researcher β’ Advocate β’ CEO at Spark Street Advisors β’ Senior Scholar at O'Neill Institute β’ Dyslexic (typos mine) β’ Writes about public health and health equity β’ www.ssc.nyc
Lawyer, Prof, Non-Profit Board Chair, Mount Allison & Schulich Law Alum
Professor in the Faculty of Health Sciences at Simon Fraser University in British Columbia, Canada. Interested in public health ethics, bioethics, philosophy, crowdfunding, and exploitation, among other things.
Seeks to understand, use, and adapt law and policy to improve health and well-being through scholarship, education and public service.
AndrΓ© Picard is the health columnist at The Globe and Mail and the author of six bestselling books. I share stories and opinion pieces from a broad range of publications. Shares are not endorsements.
Inaugural Chair, Department of Global & Public Health, McGill University. Canada Research Chair in Epidemiology & Global Health
Tweets: own views. He/him.
https://en.wikipedia.org/wiki/Madhukar_Pai
Professor, Department of Health, Society, & Behavior, School of Population & Public Health & Director, Center for Health Ethics at UCI | bioethics | public health ethics | research ethics
Access to medicines director at Public Citizen, board at Medicines Patent Pool. Lawyer (citizen.org/access), songwriter (maybarduk.com). Maiaβs dad.